The Patient Journey

Potential candidates are identified through the practice's normal patient care activities or XRS marketing initiatives.

The practice introduces the availability of regenerative medicine services through XRS. Interested patients may schedule directly with XRS or be connected through the practice.

The patient schedules an introductory consultation with an XRS Patient Care Coordinator.

The purpose of this call is to:

• Introduce regenerative medicine and the XRS program

• Explain the overall patient journey

• Discuss the role of diagnostic imaging in determining candidacy

• Answer general, non-clinical questions

• Explain the next steps in the evaluation process

• Coordinate scheduling for diagnostic imaging

• Discuss financial investment

This consultation is educational and administrative in nature. Clinical recommendations, diagnoses, and treatment decisions are not made during this call.

Patients obtain the recommended diagnostic imaging prior to their clinical consultation.

Imaging is reviewed by the XRS Nurse Practitioner before making treatment recommendations.

The patient meets with the XRS Nurse Practitioner at the partner practice for a comprehensive clinical consultation prior to any treatment.

During this visit, the provider:

• Reviews the patient's medical history

• Reviews imaging

• Establishes a diagnosis

• Determines candidacy

• Discusses treatment options

• Reviews risks and benefits

• Answers clinical questions

If the patient elects to move forward, the visit continues with:

• Confirmation of informed consent

• Final clinical assessment

• Ultrasound evaluation as clinically indicated

• Ultrasound-guided procedure

• Post-procedure instructions

• Documentation

Patients receive ongoing follow-up care to monitor progress, assess outcomes, and determine whether additional treatment or supportive therapies are indicated.

Patients continue receiving care from the provider they know and trust while benefiting from coordinated, integrated musculoskeletal care.